People: Bristol-Myers Squibb Co (BMYMP.PK)

BMYMP.PK on OTC Markets Group

1,086.14USD
1:03pm EDT
Change (% chg)

$-76.32 (-6.57%)
Prev Close
$1,162.46
Open
$1,086.14
Day's High
$1,086.14
Day's Low
$1,086.14
Volume
1
Avg. Vol
3
52-wk High
$1,182.59
52-wk Low
$805.27

Search Stocks

Sato, Vicki 

Dr. Vicki L. Sato Ph.D., is Independent Director of Bristol-Myers Squibb Co. She served as a professor of management practice at the Harvard Business School since July 2005. From July 2005 to October 2014 she served as professor of the practice of molecular and cell biology at Harvard University. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal, and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board at Vertex before being named President in 2000.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Giovanni Caforio

7,245,180

Charles Bancroft

12,054,300

Louis Schmukler

--

Francis Cuss

7,078,980

Sandra Leung

8,054,800

Paul von Autenried

--
As Of  30 Dec 2014
Search Stocks